We congratulate the eleven researchers at the Department of Cell and Molecular Biology who have been awarded grants from the Swedish Cancer Society (Cancerfonden) for the period 2025-2027. Together, the CMB researchers are awarded grants of over SEK 40 million.
Title: How MYC drives transcriptional amplification via regulation of DNA topology.
Amount granted for 2025-2027: SEK 3 750 000.
Title: Targeting the ubiquitin-proteasome system in cancer.
Amount granted for 2025-2027: SEK 5 250 000.
Title: Uncovering regionalized mechanisms of epithelial progenitor cell behaviors.
Amount granted for 2025-2027: SEK 3 000 000.
Title: Interpreting tumor single-cell and spatial transcriptomics in terms of micro-environmental drivers of tumor growth to target in therapy.
Amount granted for 2025-2027: SEK 3 000 000.
Title: Structural Biology of HSV Replication: Paving the Way for Novel Antiviral Therapies and Cancer Treatment Strategies.
Amount granted for 2025-2027: SEK 3 000 000.
Title: Oxygen metabolism, T cell function, and immunotherapeutic efficacy.
Amount granted for 2025-2027: SEK 5 250 000.
Title: Cellular heterogeneity and microenvironmental control of skin cancer.
Amount granted for 2025-2027: SEK 4 500 000.
Title: A novel route to the formation of giant polyploid cells.
Amount granted for 2025-2027: SEK 2 000 000.
Title: Mechanism of translation reprogramming and interference with ribosomal and integrated stress responses in viral oncogenesis.
Amount granted for 2025-2027: SEK 6 000 000.
Title: Targeting of Glioblastoma Stem Cells Maintaining Mechanisms.
Amount granted for 2025-2027: SEK 2 000 000.
Title: Harnessing the immunogenic potential of senescence for cancer prevention and therapy.
Amount granted for 2025-2027: SEK 3 000 000.
